Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Pfizer”
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Colorectal Cancer · Liver Metastases · Chemotherapy
France
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Chronic Disease · Immunocompromised · HIV Infection · Chronic Kidney Disease
- Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M CancersActive Not Recruiting
Sponsor: Transgene
HPV-Related Carcinoma · HPV-Related Cervical Carcinoma · HPV-Related Anal Squamous Cell Carcinoma · HPV-Related Penile Squamous Cell Carcinoma
United States, France, Spain
- SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDERActive Not Recruiting
Sponsor: Pfizer
Respiratory Syncytial Virus Infection
Japan
- Effectiveness of ABRYSVO® Maternal Respiratory Syncytial Virus (RSV) Vaccine Against RSV in Infants in Western PennsylvaniaActive Not Recruiting
Sponsor: Pfizer
Respiratory Syncytial Viruses
United States
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Metastatic Prostate Cancer
United States
- A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy AdultsActive Not Recruiting
Sponsor: Pfizer
Healthy
United States
Sponsor: Canadian Cancer Trials Group
Hodgkin Lymphoma
Australia, Canada
Sponsor: Pfizer
Healthy Adults
Belgium
- Assessing Physical Function in Sickle Cell Patients Taking VoxelotorActive Not Recruiting
Sponsor: Inova Health Care Services
Sickle Cell Disease
United States
Sponsor: Pfizer
Healthy
United States
Sponsor: Pfizer
Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Metastatic Castration Resistant Prostate Cancer (mCRPC)
Finland
Sponsor: Metsera, a wholly owned subsidiary of Pfizer
Obesity and Overweight
United States
- Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.Active Not Recruiting
Sponsor: Pfizer
Lower Respiratory Tract Illness
United States, Argentina, Canada, Finland, Japan +2 more
- Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth HormoneActive Not Recruiting
Sponsor: Pfizer
Pediatric Growth Hormone Deficiency
South Korea
Sponsor: Pfizer
Nonmetastatic Castration-Resistant Prostate Cancer · Prostate Cancer · Cancer of the Prostate
United States, Argentina, Australia, Austria, Belgium +27 more
- Effective Treatment of Jak1/3 Inhibitor in Blau SyndromeEnrolling By Invitation
Sponsor: Tongji Hospital
Blau Syndrome
China
Sponsor: Tongji Hospital
Familial Mediterranean Fever (FMF )
China
Sponsor: BioNTech SE
Influenza · COVID-19 (Coronavirus Disease 2019)
United States
Sponsor: Pfizer
Migraine
United States
- A Study of Sasanlimab in People With Non-muscle Invasive Bladder CancerActive Not Recruiting
Sponsor: Pfizer
Non-muscle Invasive Bladder Cancer
United States, Australia, Belgium, Canada, China +9 more
Sponsor: Hugo Massé-Alarie
Chronic Low-back Pain
Canada
Sponsor: Oana Danciu, MD
Hormone Receptor Positive Malignant Neoplasm of Breast · Human Epidermal Growth Factor 2 Negative Carcinoma of Breast · Estrogen Receptor Positive Breast Cancer · Progesterone Receptor Positive Tumor
United States
Sponsor: McGill University
Dementia · Mild Cognitive Impairment (MCI) · Subjective Cognitive Impairment · Parkinson's Disease (PD)
Canada
Sponsor: Pfizer
Dermatitis, Atopic
United States, Argentina, Australia, Belgium, Brazil +23 more